title: Welcome to the preexposure prophylaxis revolution.
authors.affiliation: aDepartment of Global Health bDepartment of Medicine cDepartment of Epidemiology, University of Washington, Seattle, USA dMedical Research Council Clinical Trials Unit at UCL, London, UK.
authors.forename: Jared
authors.initials: J
authors.lastname: Baeten
authors.forename: Sheena
authors.initials: S
authors.lastname: McCormack
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D018890:Chemoprevention / Q000379:methods*; D003695:Delivery of Health Care / Q000458:organization & administration*; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D000068679:Emtricitabine / Q000008:administration & dosage; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D008297:Male; D055118:Medication Adherence; D065129:Pre-Exposure Prophylaxis / Q000379:methods* / Q000458:organization & administration*; D000068698:Tenofovir / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D000068698:Tenofovir; D000068679:Emtricitabine